1. Home
  2. MCB vs NNNN Comparison

MCB vs NNNN Comparison

Compare MCB & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$98.01

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$11.54

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
NNNN
Founded
1999
2021
Country
United States
Germany
Employees
N/A
27
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
MCB
NNNN
Price
$98.01
$11.54
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$98.67
N/A
AVG Volume (30 Days)
133.7K
43.2K
Earning Date
04-21-2026
04-07-2026
Dividend Yield
1.13%
N/A
EPS Growth
11.64
N/A
EPS
2.92
N/A
Revenue
$11,053,000.00
N/A
Revenue This Year
$37.22
N/A
Revenue Next Year
$14.75
N/A
P/E Ratio
$32.89
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$64.66
$10.50
52 Week High
$102.04
$55.65

Technical Indicators

Market Signals
Indicator
MCB
NNNN
Relative Strength Index (RSI) 56.25 27.50
Support Level $86.38 $10.50
Resistance Level N/A $30.21
Average True Range (ATR) 2.53 1.92
MACD -0.26 0.05
Stochastic Oscillator 55.86 9.99

Price Performance

Historical Comparison
MCB
NNNN

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: